Option Care Health, Inc.
OPCHNASDAQHealthcare● Active
$20.08
$-0.43(-2.10%)
Market Cap$3.2B
P/E Ratio—
52W High$36.8
52W Low$18.01
Option Care Health, Inc. (OPCH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OPCH · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$0.40
Est. $0.37 · +8.1%
Revenue
$1.35B
Est. $1.39B · -2.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue🔥 11-Quarter EPS Beat Streak
OPCH reports quarterly as a NASDAQ-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | $0.42 | — | — | — | $1.42B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | $0.37 | $0.40 | +8.1% | $1.35B | $1.39B | -2.8% |
| — Q1 FY2026 | Feb 24, 2026 | $0.46 | $0.46 | +0.0% | $1.47B | $1.46B | +0.3% |
| ▲ Q4 FY2025 | Oct 30, 2025 | $0.43 | $0.45 | +4.7% | $1.44B | $1.46B | -1.9% |
| ▲ Q3 FY2025 | Jul 30, 2025 | $0.40 | $0.41 | +2.5% | $1.42B | $1.40B | +1.0% |
| ▲ Q2 FY2025 | Apr 29, 2025 | $0.36 | $0.40 | +11.1% | $1.33B | $1.34B | -0.2% |
| ▲ Q1 FY2025 | Feb 26, 2025 | $0.33 | $0.35 | +6.1% | $1.35B | $1.23B | +9.5% |
| — Q4 FY2024 | Oct 30, 2024 | $0.31 | $0.31 | +0.0% | $1.28B | $1.27B | +0.7% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
$0.42
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
$0.40
EPS Est.
$0.37
EPS Surpr.
+8.1%
Revenue
$1.35B
Q1 FY2026
Feb 24, 2026
EPS Actual
$0.46
EPS Est.
$0.46
EPS Surpr.
+0.0%
Revenue
$1.47B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$0.45
EPS Est.
$0.43
EPS Surpr.
+4.7%
Revenue
$1.44B
Q3 FY2025
Jul 30, 2025Beat
EPS Actual
$0.41
EPS Est.
$0.40
EPS Surpr.
+2.5%
Revenue
$1.42B
Q2 FY2025
Apr 29, 2025Beat
EPS Actual
$0.40
EPS Est.
$0.36
EPS Surpr.
+11.1%
Revenue
$1.33B
Q1 FY2025
Feb 26, 2025Beat
EPS Actual
$0.35
EPS Est.
$0.33
EPS Surpr.
+6.1%
Revenue
$1.35B
Q4 FY2024
Oct 30, 2024
EPS Actual
$0.31
EPS Est.
$0.31
EPS Surpr.
+0.0%
Revenue
$1.28B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $0.74 | $0.75 | $0.76 | 2 |
| Q3 FY2029 | $0.67 | $0.68 | $0.69 | 2 |
| Q2 FY2029 | $0.60 | $0.61 | $0.62 | 2 |
| Q1 FY2029 | $0.53 | $0.54 | $0.54 | 4 |
| Q4 FY2028 | $0.67 | $0.68 | $0.68 | 5 |
| Q3 FY2028 | $0.58 | $0.59 | $0.59 | 5 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $2.0B | $2.0B | $2.0B | 3 |
| Q3 FY2029 | $1.9B | $1.9B | $1.9B | 3 |
| Q2 FY2029 | $1.9B | $1.9B | $1.9B | 3 |
| Q1 FY2029 | $1.8B | $1.8B | $1.8B | 5 |
| Q4 FY2028 | $1.7B | $1.7B | $1.8B | 4 |
| Q3 FY2028 | $1.7B | $1.7B | $1.7B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +8.1% | $26.87 | $20.33 | -24.34% |
| ▲ Q1 FY2026 | Feb 24, 2026 | +0.0% | $36.09 | $33.82 | -6.29% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +4.7% | $28.67 | $26.21 | -8.58% |
| ▲ Q3 FY2025 | Jul 30, 2025 | +2.5% | $30.13 | $30.64 | +1.69% |
| ▲ Q2 FY2025 | Apr 29, 2025 | +11.1% | $32.97 | $30.69 | -6.92% |
| ▲ Q1 FY2025 | Feb 26, 2025 | +6.1% | $32.63 | $33.15 | +1.59% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +0.0% | $30.50 | $23.55 | -22.79% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +11.1% | $31.35 | $29.69 | -5.30% |
Q2 FY2026-24.34%
Report Date
Apr 30, 2026
EPS Beat/Miss
+8.1%
Price Before
$26.87
Price After
$20.33
Q1 FY2026-6.29%
Report Date
Feb 24, 2026
EPS Beat/Miss
+0.0%
Price Before
$36.09
Price After
$33.82
Q4 FY2025-8.58%
Report Date
Oct 30, 2025
EPS Beat/Miss
+4.7%
Price Before
$28.67
Price After
$26.21
Q3 FY2025+1.69%
Report Date
Jul 30, 2025
EPS Beat/Miss
+2.5%
Price Before
$30.13
Price After
$30.64
Q2 FY2025-6.92%
Report Date
Apr 29, 2025
EPS Beat/Miss
+11.1%
Price Before
$32.97
Price After
$30.69
Q1 FY2025+1.59%
Report Date
Feb 26, 2025
EPS Beat/Miss
+6.1%
Price Before
$32.63
Price After
$33.15
Q4 FY2024-22.79%
Report Date
Oct 30, 2024
EPS Beat/Miss
+0.0%
Price Before
$30.50
Price After
$23.55
Q3 FY2024-5.30%
Report Date
Jul 31, 2024
EPS Beat/Miss
+11.1%
Price Before
$31.35
Price After
$29.69
Avg Beat Reaction-8.87%
Beat Rate8 / 8 quarters
Largest Move-24.34% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OPCH ends December
Option Care Health, Inc. (OPCH) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $0.40 — beating the analyst consensus of $0.37 by +8.1%. OPCH has beaten EPS estimates for 11 consecutive quarters. The next OPCH earnings date is expected around September 1, 2026.
Each quarter, investors track OPCH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OPCH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OPCH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OPCH earnings · 5 questionsOption Care Health, Inc.'s next earnings report is expected around September 1, 2026. OPCH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OPCH historically reports after market close (AMC).
OPCH earnings datewhen is OPCH earningsOPCH next earnings datewhen does OPCH report earningsOPCH earnings calendar
▸ Source: FMP · Option Care Health, Inc. SEC filings · US GAAP · Option Care Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026